Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Plus Therapeutics, a clinical-stage healthcare company specializing in precision diagnostics and radiopharmaceuticals for CNS cancers, announced that it has regained compliance with Nasdaq's minimum bid price rule. The company's stock maintained a closing bid price above $1.00 for 10 consecutive trading days, ensuring continued listing on Nasdaq.
United Community Banks, Inc. announced net income of $84.3 million and diluted EPS of $0.69 for Q1 2026, showing significant improvement from the prior year. The bank achieved strong revenue growth, a widened net interest margin, and loan growth supported by increased customer deposits. It also declared a quarterly dividend increase, repurchased sh…
Serve Robotics Inc., a Nasdaq-listed autonomous robotics company, announces its first quarter 2026 financial results release on May 7, 2026, followed by a conference call and webcast. The company recently expanded into indoor service robots through acquisition and continues to operate thousands of autonomous delivery robots across the U.S.
PMGC Holdings Inc.'s subsidiary, SVM Machining, Inc., has entered a long-term agreement with Turbo-Jet Products Co., Inc. to supply aerospace and defense components over an initial five-year term with annual renewal options. This agreement enhances SVM's strategic position in the aerospace and defense supply chain and compliance with government reg…
J.P. Morgan scenario analysis indicates Europe could see commercial jet fuel stock cover fall below critical levels as early as June if current replacement rates for Middle East supplies hold. Structural reliance on imports, limited refinery flexibility and modest pre-conflict inventories leave the region exposed, with strategic reserves providing …
Pope Leo arrived in Malabo, Equatorial Guinea, on the last leg of a four-nation Africa tour marked by direct criticisms of authoritarianism and economic inequality. Coming from Angola, where he accused people of being "exploited by authoritarians and defrauded by the rich," the pope paid respects to his predecessor and prepared to meet President Te…
Northrop Grumman Corporation released its financial results for the first quarter of 2026 and scheduled a live webcast of its earnings conference call to provide detailed insights to investors. The company continues to focus on delivering advanced aerospace and defense technology solutions.
Silicon Motion (SIMO) looks set to extend its run as enterprise-grade SSD demand accelerates. Q4 2025 revenue strength, aggressive Q1 2026 guidance and bullish technicals provide a clear trade entry with defined risk-reward into the company’s next print and product ramps.
The Simply Good Foods Company announced strategic cost savings and organizational realignment initiatives, including leadership changes, aimed at simplifying the company structure, improving operational efficiency, and positioning the business for future growth within the nutritional snacking sector. These initiatives are expected to yield approxim…
Apple’s leadership change marks the beginning of a new phase in which the company must demonstrate it can meld its long-standing hardware expertise with generative AI capabilities to sustain growth. Analysts say the incoming CEO, John Ternus, will be judged on how he addresses intensifying AI competition, Washington policy pressures around reshorin…
RTX has increased its full-year 2026 profit and revenue forecasts after reporting stronger first-quarter results driven by heightened demand for missile systems, expanded aftermarket sales and growth in aircraft maintenance. The company highlighted a $3.7 billion Patriot GEM-T interceptor contract for Ukraine and double-digit growth in its Raytheon…
Goldman Sachs downgraded M&G Plc to a neutral rating and reduced its 12-month price target to 320p from 330p after the British insurer’s shares climbed more than 50% over the prior 12 months. The broker cited stretched valuation metrics, a compressed dividend yield, and revised earnings forecasts driven by recent market movements, while noting ongo…
Red Cat (RCAT) is a small but fast-growing defense drone play. With FY2025 revenue of $40.7M and strategic wins—Apium acquisition, Ukraine partnership, and first Black Widow order—upcoming Q1 results (05/07/2026) are a catalytic mid-term event. The stock is volatile and richly valued, but technicals, short-interest dynamics, and program-level deman…
Tech equities continued to absorb geopolitical strain this week, with AI-driven optimism and large strategic investments supporting gains across Asia even as the two-week U.S.-Iran ceasefire approaches expiry on Wednesday. Wall Street paused early in the week, but futures recovered and technology-led moves pushed markets in South Korea, Japan and T…
Tecnoglass, a leading producer of aluminum and vinyl windows and architectural glass, is set to release its first quarter 2026 financial results on May 7, 2026. The company will host a webcast and conference call to discuss the results, enabling investors to gain insights into its performance.
LeonaBio, Inc. announced that independent nonclinical research presented at the AACR26 conference validates the potential of its drug candidate lasofoxifene as a selective estrogen receptor modulator for treating metastatic ER-positive breast cancer, particularly in patients with ESR1 mutations. The data demonstrate lasofoxifene's dual role in supp…
KALA BIO celebrates a recent US executive order prioritizing psychedelic drug review, reducing DEA research restrictions, and allocating $50 million for psychedelic therapy research. The company highlights its AI platform, Researgency.ai, which supports clients like Red Light Holland in advancing their psychedelic drug development programs under th…
Guardforce AI announced its financial results for the full year 2025, showing an 8% increase in total revenue to $35.2 million, driven by growth in AI, Robotics-as-a-Service, and Smart Solutions. The company launched the AI Agent DeepVoyage Go and expanded smart retail solutions in Thailand. Despite a net loss, the loss narrowed by 10%, and negativ…
XORTX Therapeutics Inc. announced that it has regained compliance with Nasdaq's minimum bid price rule following a 1-for-5 reverse stock split that elevated its share price above the required $1.00 threshold. The company received a official letter of compliance from Nasdaq, curing the deficiency. XORTX is a late-stage clinical pharmaceutical compan…
Mobilicom Limited has received $2.2 million in new purchase orders from a major U.S. defense drone manufacturer as part of a $249 million Program of Record with the U.S. Department of War. These orders reflect an increase from previous engagements under the same program. Deliveries have commenced and will continue through 2026. Mobilicom's cybersec…
Rezolute, Inc., a rare disease biopharmaceutical company, announced that results from its Phase 3 sunRIZE study evaluating ersodetug in treating congenital hyperinsulinism (HI) will be presented at the Pediatric Endocrine Society Annual Meeting. The study showed promising therapeutic benefits of ersodetug, an antibody designed to reduce hypoglycemi…
BioAge Labs announced positive Phase 1 clinical trial results for BGE-102, a novel oral NLRP3 inhibitor targeting inflammation related to aging and cardiovascular risk. The drug demonstrated significant reductions in hsCRP and other inflammatory biomarkers in obese participants, with good tolerability. Based on these results, BioAge plans to initia…
Eupraxia Pharmaceuticals announced positive 36-week clinical and tissue health data from the highest dose cohort (Cohort 9) of their ongoing Phase 1b/2a RESOLVE trial of EP-104GI, a novel treatment for eosinophilic esophagitis (EoE). The highest dose cohort showed substantial improvement in tissue health and symptom remission rates with no serious …
Vicor Corporation announced its Q1 2026 financial results showing a 20.2% year-over-year increase in product and royalty revenues to $113 million, improved gross margins, and a significant 75% increase in backlog compared to the previous year. Net income surged to $20.7 million from $2.5 million a year ago. The company plans to expand manufacturing…
Standard BioTools Inc., a NASDAQ-listed provider of next-generation biomedical research technologies, announced it will publish its first quarter 2026 financial results on May 5, 2026, after the U.S. market closes.
